COMP <GO>
KOD vs JNJ // RETURN ON INVESTED CAPITAL (ROIC)
Kodiak Sciences Inc (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: KOD 3
— JNJ 10
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: JNJ
LAST: $99.18 (-1.22%) • MKT CAP: $6.31B
roic
-35.00%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
roic
25.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KOD VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KOD | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 67.90% | -26.90 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | 25.50% | -60.50 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.16% | 2.97% | -5.13 | JNJ | /fcf-yield <GO> |
| Operating Margin | -13.30% | 34.70% | -48.00 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -13.00% | 28.50% | -41.50 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 1.10% | 6.00% | -4.90 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 16.70 | 5.59 | +11.11 | KOD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 7.20% | -0.60 | KOD | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.5 | 60.4 | +6.10 | KOD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 1.08 | -0.18 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 35.0x | 23.0x | +12.00 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.31B | $662.49B | -$656.18B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KOD REV | JNJ REV | KOD GROSS % | JNJ GROSS % | KOD FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $94.19B | — | 67.9% | -$136.5M | $19.70B |
| FY 2024 | $0 | $88.82B | — | 69.1% | -$117.7M | $19.84B |
| FY 2023 | $0 | $85.16B | — | 44.0% | -$154.2M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KOD // BETA 0.90
JNJ // BETA 1.08